Common use of Deviation Report Clause in Contracts

Deviation Report. If during the manufacture, processing, storage, distribution, testing, transport, disposal or other handling of PPF by Supplier there arises a result that is classified as either a Type I Incident or a Type II Incident (as defined below), then Supplier shall prepare within seven (7) days following the discovery of such deviation a written report detailing such deviation (a “Deviation Report”) and promptly send to Bayer such Deviation Report prior to Supplier’s delivery of the PPF which is the subject of such report. If Bayer rejects a shipment of PPF based on a Deviation Report, it shall promptly notify Supplier, such PPF shall be considered a Nonconforming Product and the provisions of Section 7.1 shall apply. For purposes of this Agreement, a “Type I Incident” shall be defined as an unexpected result that has potential serious impact on product safety, identity, strength, quality, purity, efficacy or manufacturing/testing process. Examples of Type I Incidents include final product sterility and stability failure, media fill failure, pyrogen specification exceeded for bulk or final container and inadequate viral inactivation process. For purposes of this Agreement, a “Type II Incident” shall be defined as an unexpected result that has the potential to affect product safety, identity, strength, quality, purity, efficacy or manufacturing/testing process. Examples of Type II Incidents include clean steam exceeding action level for LAL and Presterile in-process bioburden exceeding action level.

Appears in 3 contracts

Samples: Supply Agreement (Talecris Biotherapeutics Holdings Corp.), Supply Agreement (Talecris Biotherapeutics Holdings Corp.), Supply Agreement (Talecris Biotherapeutics Holdings Corp.)

AutoNDA by SimpleDocs

Deviation Report. (i) If during the manufacture, processing, storage, distribution, testing, transport, disposal or other handling Manufacture of PPF the Contractual Products by Supplier there Talecris Inc. these arises a result that is classified as either a Type I Incident or a Type II Incident (as defined below)Incident, then Supplier Talecris GmbH shall prepare ensure that Talecris Inc. prepares within seven (7) days following the discovery of such deviation a written report detailing such deviation (a “Deviation Report”) and promptly send to Bayer Xxxxx such Deviation Report prior to SupplierTalecris GmbH’s delivery of the PPF Contractual Products which is are the subject of such report. If Bayer Xxxxx rejects a shipment of PPF the Contractual Products based on a Deviation Report, it shall promptly notify SupplierTalecris GmbH, such PPF Contractual Products shall be considered a Nonconforming Product Products and the provisions of Section 7.1 12.1 shall apply. For purposes of this Agreement, a “Type I Incident” shall be defined as an unexpected result that has potential serious impact on product safety, identity, strength, quality, purity, efficacy or manufacturing/testing process. Examples of Type I Incidents include final product sterility and stability failure, media fill failure, pyrogen specification exceeded for bulk or final container and inadequate viral inactivation process. For purposes of this Agreement, a “Type II Incident” shall be defined as an unexpected result that has the potential to affect product safety, identity, strength, quality, purity, efficacy efficacy, or manufacturing/testing processprocess performance. Examples of Type II Incidents include clean steam exceeding action level for LAL and Presterile Pre sterile in-process bioburden exceeding action level.

Appears in 2 contracts

Samples: European Product Sales Agreement (Talecris Biotherapeutics Holdings Corp.), European Product Sales Agreement (Talecris Biotherapeutics Holdings Corp.)

AutoNDA by SimpleDocs

Deviation Report. (i) If during the manufacture, processing, storage, distribution, testing, transport, disposal or other handling of PPF the Products by Supplier Bayer there arises a result that is classified as either a Type I Incident or a Type II Incident (as defined below), then Supplier Bayer shall prepare within seven (7) days following the discovery of such deviation a written report detailing such deviation (a “Deviation Report”) and promptly send to Bayer Purchaser such Deviation Report prior to SupplierBayer’s delivery of the PPF Products which is the subject of such report. If Bayer Purchaser rejects a shipment of PPF the Products based on a Deviation Report, it shall promptly notify SupplierBayer, such PPF Products shall be considered a Nonconforming Product Products and the provisions of Section 7.1 6.1 shall apply. For purposes of this Agreement, a “Type I Incident” shall be defined as an unexpected result that has potential serious impact on product safety, identity, strength, quality, purity, efficacy or manufacturing/testing process. Examples of Type I Incidents include final product sterility and stability failure, media fill failure, pyrogen specification exceeded for bulk or final container and inadequate viral inactivation process. For purposes of this Agreement, a “Type II Incident” shall be defined as an unexpected result that has the potential to affect product safety, identity, strength, quality, purity, efficacy efficacy, or manufacturing/testing process. Examples of Type II Incidents include clean steam exceeding action level for LAL and Presterile in-process bioburden exceeding action level.

Appears in 2 contracts

Samples: Manufacturing Agreement (Talecris Biotherapeutics Holdings Corp.), Manufacturing Agreement (Talecris Biotherapeutics Holdings Corp.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!